Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
Authors
Keywords
DNA methylation, Platinum, Ovarian cancer, Cancer treatment, EGFR signaling, Drug therapy, Cell signaling, Methylation
Journal
PLoS One
Volume 10, Issue 9, Pages e0136893
Publisher
Public Library of Science (PLoS)
Online
2015-09-10
DOI
10.1371/journal.pone.0136893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decitabine reactivated pathways in platinum resistant ovarian cancer
- (2015) Fang Fang et al. Oncotarget
- A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
- (2014) R M Glasspool et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Treatment of ovarian cancer beyond chemotherapy: Are we hitting the target?
- (2014) Álvaro Henrique Ingles Garces et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Epigenetic Targeting of Ovarian Cancer Stem Cells
- (2014) Yinu Wang et al. CANCER RESEARCH
- The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
- (2014) F. Fang et al. CLINICAL CANCER RESEARCH
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer
- (2013) Madhuri Koti et al. BMC CANCER
- Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
- (2013) F Meng et al. BRITISH JOURNAL OF CANCER
- Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study
- (2013) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma
- (2013) Hal Hirte OncoTargets and Therapy
- Redox Regulation of Epidermal Growth Factor Receptor Signaling through Cysteine Oxidation
- (2012) Thu H. Truong et al. BIOCHEMISTRY
- The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
- (2012) Ting Gui et al. Cancer Epidemiology
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
- (2012) Ignacio Romero et al. ENDOCRINOLOGY
- Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells
- (2012) Sabrina L. Samudio-Ruiz et al. Epigenetics
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Jak/Stat3 Signaling Promotes Somatic Cell Reprogramming by Epigenetic Regulation
- (2012) Yong Tang et al. STEM CELLS
- The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
- (2011) Q Sheng et al. BRITISH JOURNAL OF CANCER
- EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment
- (2011) G. Liccardi et al. CANCER RESEARCH
- Regulation of mammalian DNA methyltransferases: a route to new mechanisms
- (2011) Hélène Denis et al. EMBO REPORTS
- Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
- (2011) P Yue et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
- (2010) Dong-Jun Peng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells
- (2010) Daniela Loessner et al. BIOMATERIALS
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human Cancers
- (2010) Xiaofei Chang et al. CANCER RESEARCH
- A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)
- (2010) H. Hirte et al. GYNECOLOGIC ONCOLOGY
- Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
- (2010) Stephanie V. Blank et al. GYNECOLOGIC ONCOLOGY
- Epigenetics of ovarian cancer: From the lab to the clinic
- (2010) Reza Asadollahi et al. GYNECOLOGIC ONCOLOGY
- Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
- (2009) Meng Li et al. BMC Medical Genomics
- EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma
- (2009) Laurie G Hudson et al. Future Oncology
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
- Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
- (2009) Daniela E. Matei et al. GYNECOLOGIC ONCOLOGY
- EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
- (2009) Yukihiro Hiraishi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Targeting the EGF Receptor for Ovarian Cancer Therapy
- (2009) Reema Zeineldin et al. Journal of Oncology
- Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
- (2009) Doris R. Siwak et al. Journal of Oncology
- Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression
- (2008) Laurie G. Hudson et al. CLINICAL & EXPERIMENTAL METASTASIS
- The anti-EGFR monoclonal antibody blocks cisplatin-induced activation of EGFR signaling mediated by HB-EGF
- (2008) Takeshi Yoshida et al. FEBS LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started